Barton Shane
Principal Accounting Officer at BIOA
- Sold, on record
- $1.6M
- Dollars the filings state
- Form 4 sales
- 1
- Latest Jun 30, 2026
- Form 144 notices
- 2
- Proposed sales
- Quarters with a sale
- 1 of the last 8
- 1 day with a sale in that time
- Companies
- 1
- Filed as an executive or holder
Companies
- BIOABioAge Labs, Inc.Principal Accounting Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
1
Unusual
Form 4 sales per month, every sale on record.
Timeline
- Jun 30, 2026Unusual
Sold 100% of their holdings
$1.6M62,566 shares at $25.20
- Jun 30, 2026Notice
Filed a notice to sell 20,216 shares
$509k20,216 shares
- Jun 29, 2026Notice
Filed a notice to sell 42,350 shares
$1.1M42,350 shares
3 of 3
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 1, 2026 | BIOA | Principal Accounting Officer | Sold | 62,566 | $25.20 | $1.6M | 0 | SEC |
| Jun 30, 2026 | Jul 1, 2026 | BIOA | Principal Accounting Officer | Exercised or settledStock Option (Right to Buy) | 59,934 | 67,941 | SEC | ||
| Jun 30, 2026 | Jul 1, 2026 | BIOA | Principal Accounting Officer | Exercised options | 59,934 | $6.58 | $395k | 20,216 | SEC |
| Feb 17, 2026 | Feb 19, 2026 | BIOA | Principal Accounting Officer | AwardedStock Option (Right to Buy) | 45,000 | 45,000 | SEC | ||
| Feb 18, 2025 | Feb 20, 2025 | BIOA | Principal Accounting Officer | AwardedStock Option (Right to Buy) | 90,000 | 90,000 | SEC | ||
| Dec 18, 2024 | Dec 20, 2024 | BIOA | Principal Accounting Officer | AwardedStock Option (Right to Buy) | 40,000 | 40,000 | SEC | ||
| Sep 27, 2024 | Mar 10, 2025 | BIOA | Principal Accounting Officer | Bought | 2,632 | $18.00 | $47k | 2,632 | SEC |
| Jun 7, 2023 | Jun 9, 2023 | DTIL | VP & Corporate Controller | Exercised or settledRestricted Stock Units | 6,060 | 6,060 | SEC | ||
| Jun 7, 2023 | Jun 9, 2023 | DTIL | VP & Corporate Controller | Exercised options | 6,060 | 27,502 | SEC | ||
| Mar 3, 2023 | Mar 7, 2023 | DTIL | VP & Corporate Controller | Exercised or settledRestricted Stock Units | 12,722 | 25,439 | SEC | ||
| Mar 3, 2023 | Mar 7, 2023 | DTIL | VP & Corporate Controller | Exercised options | 12,722 | 21,422 | SEC | ||
| Jan 20, 2023 | Jan 24, 2023 | DTIL | VP & Corporate Controller | AwardedRestricted Stock Units | 70,000 | 70,000 | SEC | ||
| Jun 7, 2022 | Jun 9, 2022 | DTIL | VP & Corporate Controller | Exercised or settledRestricted Stock Units | 6,061 | 12,120 | SEC | ||
| Jun 7, 2022 | Jun 9, 2022 | DTIL | VP & Corporate Controller | Exercised options | 6,061 | 8,720 | SEC | ||
| Mar 3, 2022 | Mar 7, 2022 | DTIL | VP & Corporate Controller | AwardedEmployee Stock Option (Right to Buy) | 98,765 | 38,161 | SEC | ||
| Feb 28, 2022 | Mar 7, 2022 | DTIL | VP & Corporate Controller | Awarded | 2,659 | $5.70 | $15k | 2,659 | SEC |
| Jun 7, 2021 | Jun 9, 2021 | DTIL | VP & Corporate Controller | AwardedEmployee Stock Option (Right to Buy) | 49,423 | 18,181 | SEC |
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 1, 2026 | BIOA | Principal Accounting Officer | Form 4 sale | 62,566 | $1.6M | 100.0% | Unusual | SEC |
| Jun 30, 2026 | Jun 30, 2026 | BIOA | Principal Accounting Officer | Form 144 notice | 20,216 | $509k | Notice | SEC | |
| Jun 29, 2026 | Jun 29, 2026 | BIOA | Principal Accounting Officer | Form 144 notice | 42,350 | $1.1M | Notice | SEC |